by Nakita | Jun 24, 2026 | Latest News
We are excited that the updated British Society for Rheumatology (BSR) guidelines for lupus have been published. This update represents a huge amount of progress in research, understanding, and treatment since the first UK guidelines were published almost ten years...
by Nakita | Jun 18, 2026 | Blog, Latest News
We are delighted to welcome Eleanor and Ann-Marie to the Lupus UK Staff Team! Eleanor has joined the Fundraising & Marketing Development team as our Fundraising & Stewardship Officer, and Ann-Marie has joined the Community Services team as our Community...
by Nakita | Jun 11, 2026 | Latest News, Research Opportunities
In this article, we use “lupus” instead of “SLE” (systemic lupus erythematosus). In England and Wales, doctors can use a medicine called obinutuzumab to treat kidney disease caused by lupus. You might know this as lupus nephritis. Research has shown that obinutuzumab...
by Nakita | May 22, 2026 | Latest News
People living with immune-mediated inflammatory diseases (IMIDs), including lupus, in Scotland face persistent challenges in accessing timely diagnosis, equitable care, and the support needed to manage lifelong, complex conditions. The Scottish Report, led by the...
by Nakita | Feb 28, 2026 | Latest News
NICE publishes Quality Standard for rare disease NICE has published a Quality Standard for Rare Disease which sets out what high-quality sustainable care, treatment, and management should look like for rare diseases. We hope that this will help improve services, care,...
by Nakita | Jan 22, 2026 | Latest News
NICE approves obinutuzumab to treat lupus nephritis in England and Wales NICE have recommended that a new treatment, obinutuzumab, can be used in combination with mycophenolate mofetil (MMF) to treat some patients with lupus nephritis in the NHS in England and Wales. ...
